464 related articles for article (PubMed ID: 37619529)
21. Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies.
Pan W; Kang Y
Int Urol Nephrol; 2018 Feb; 50(2):289-299. PubMed ID: 28849345
[TBL] [Abstract][Full Text] [Related]
22. The Impact of CKD on Uremic Toxins and Gut Microbiota.
Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
[TBL] [Abstract][Full Text] [Related]
23. Novel intestinal dialysis interventions and microbiome modulation to control uremia.
Sumida K; Lau WL; Kalantar-Zadeh K; Kovesdy CP
Curr Opin Nephrol Hypertens; 2022 Jan; 31(1):82-91. PubMed ID: 34846313
[TBL] [Abstract][Full Text] [Related]
24. The Potential Role of Gut Microbiota in Alzheimer's Disease: From Diagnosis to Treatment.
Varesi A; Pierella E; Romeo M; Piccini GB; Alfano C; Bjørklund G; Oppong A; Ricevuti G; Esposito C; Chirumbolo S; Pascale A
Nutrients; 2022 Feb; 14(3):. PubMed ID: 35277027
[TBL] [Abstract][Full Text] [Related]
25. Characterizing the gut microbiota in patients with chronic kidney disease.
Hu X; Ouyang S; Xie Y; Gong Z; Du J
Postgrad Med; 2020 Aug; 132(6):495-505. PubMed ID: 32241215
[No Abstract] [Full Text] [Related]
26. Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis.
Haak BW; Prescott HC; Wiersinga WJ
Front Immunol; 2018; 9():2042. PubMed ID: 30250472
[TBL] [Abstract][Full Text] [Related]
27. Gut microbiota dysbiosis and Huntington's disease: Exploring the gut-brain axis and novel microbiota-based interventions.
Sharma G; Biswas SS; Mishra J; Navik U; Kandimalla R; Reddy PH; Bhatti GK; Bhatti JS
Life Sci; 2023 Sep; 328():121882. PubMed ID: 37356750
[TBL] [Abstract][Full Text] [Related]
28. Microbiota metabolites: Pivotal players of cardiovascular damage in chronic kidney disease.
Cosola C; Rocchetti MT; Cupisti A; Gesualdo L
Pharmacol Res; 2018 Apr; 130():132-142. PubMed ID: 29518493
[TBL] [Abstract][Full Text] [Related]
29. Gut microbiome in chronic kidney disease: challenges and opportunities.
Nallu A; Sharma S; Ramezani A; Muralidharan J; Raj D
Transl Res; 2017 Jan; 179():24-37. PubMed ID: 27187743
[TBL] [Abstract][Full Text] [Related]
30. [The gut microbiota, a new cardiovascular risk factor?].
Chong-Nguyen C; Duboc H; Sokol H
Presse Med; 2017; 46(7-8 Pt 1):708-713. PubMed ID: 28756077
[TBL] [Abstract][Full Text] [Related]
31. Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review.
Dai Y; Shen Z; Khachatryan LG; Vadiyan DE; Karampoor S; Mirzaei R
Pathol Res Pract; 2023 Sep; 249():154740. PubMed ID: 37567034
[TBL] [Abstract][Full Text] [Related]
32. The Potential Benefits and Controversies of Probiotics Use in Patients at Different Stages of Chronic Kidney Disease.
Tian N; Li L; Ng JK; Li PK
Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235699
[TBL] [Abstract][Full Text] [Related]
33. Effect of Probiotic, Prebiotic, and Synbiotic Supplementation on Cardiometabolic and Oxidative Stress Parameters in Patients With Chronic Kidney Disease: A Systematic Review and Meta-analysis.
Bakhtiary M; Morvaridzadeh M; Agah S; Rahimlou M; Christopher E; Zadro JR; Heshmati J
Clin Ther; 2021 Mar; 43(3):e71-e96. PubMed ID: 33526314
[TBL] [Abstract][Full Text] [Related]
34. A systematic review of microbiome changes and impact of probiotic supplementation in children and adolescents with neuropsychiatric disorders.
Ligezka AN; Sonmez AI; Corral-Frias MP; Golebiowski R; Lynch B; Croarkin PE; Romanowicz M
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110187. PubMed ID: 33271210
[TBL] [Abstract][Full Text] [Related]
35. Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies.
Shabbir U; Arshad MS; Sameen A; Oh DH
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33669988
[TBL] [Abstract][Full Text] [Related]
36. Gut microbiome-targeted therapies for Alzheimer's disease.
Zhang T; Gao G; Kwok LY; Sun Z
Gut Microbes; 2023 Dec; 15(2):2271613. PubMed ID: 37934614
[TBL] [Abstract][Full Text] [Related]
37. Association between gut dysbiosis and chronic kidney disease: a narrative review of the literature.
Feng Z; Wang T; Dong S; Jiang H; Zhang J; Raza HK; Lei G
J Int Med Res; 2021 Oct; 49(10):3000605211053276. PubMed ID: 34704483
[TBL] [Abstract][Full Text] [Related]
38. Gut Microbiome in Chronic Kidney Disease.
Armani RG; Ramezani A; Yasir A; Sharama S; Canziani MEF; Raj DS
Curr Hypertens Rep; 2017 Apr; 19(4):29. PubMed ID: 28343357
[TBL] [Abstract][Full Text] [Related]
39. Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease.
Chen YY; Chen DQ; Chen L; Liu JR; Vaziri ND; Guo Y; Zhao YY
J Transl Med; 2019 Jan; 17(1):5. PubMed ID: 30602367
[TBL] [Abstract][Full Text] [Related]
40. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].
Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J
Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
